River BioMedics paves the way to the future of cardiac drug discovery

Closer to the heart

We bring new ways for drug discovery on cardiac disease using human predictive 3D cardiac models. We combine our cardiac biology know-how with our expertise in bio-engineering and human induced pluripotent stem cells (hiPSC) for a more successful drug discovery pipeline.

Targeting the heart muscle

Human predictive models

Human induced pluripotent stem cell technology 

Highly versatile custom-made shapes and co-cultures

Detailed clinically relevant read-outs

High-throughput scalable screening platforms

We strive novelty

We mimic nature

We connect biology and engineering

We develop new therapies

We value partnership

We listen to patient needs

Cardiovascular disease the

number one cause of death worldwide

We develop new therapies for cardiac disease by targeting the muscle that makes our heart beat

Meet the team

We take on the challenge to bring cardiac drug development to the next level

Marcelo Ribeiro

Scientific and corporate development

Co-founder

Lisanne Blauw

Business and corporate development

Co-founder

Robert Passier

Scientific advisor

Co-founder

John Verhoeven

Business strategy advisor

Tom Boonen

Research and product development

Recent News

Read More